These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30123880)

  • 21. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
    Kontodimopoulos N; Ntinoulis K; Niakas D
    Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the acceptability, reliability, and validity of the EORTC Quality of Life Questionnaire (QLQ-C30) in Kenyan cancer patients: a cross-sectional study.
    Davda J; Kibet H; Achieng E; Atundo L; Komen T
    J Patient Rep Outcomes; 2021 Jan; 5(1):4. PubMed ID: 33415528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia.
    Imran M; Al-Wassia R; Alkhayyat SS; Baig M; Al-Saati BA
    PLoS One; 2019; 14(7):e0219093. PubMed ID: 31291302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of quality of life of Turkish breast cancer patients receiving breast conserving surgery or modified radical mastectomy.
    Acil H; Cavdar I
    Asian Pac J Cancer Prev; 2014; 15(13):5377-81. PubMed ID: 25041005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life assessment of breast cancer patients in Saudi Arabia.
    Nageeti TH; Elzahrany HR; Gabra AO; Obaid AA; Jastania RA
    J Family Community Med; 2019; 26(2):98-102. PubMed ID: 31143080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
    Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
    Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health - related quality of life of Kuwaiti women with breast cancer: a comparative study using the EORTC Quality of Life Questionnaire.
    Alawadi SA; Ohaeri JU
    BMC Cancer; 2009 Jul; 9():222. PubMed ID: 19586536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-Sectional Patient-Reported Outcome Measuring of Health-Related Quality of Life With Establishment of Cancer- and Treatment-Specific Functional and Symptom Scales in Patients With Penile Cancer.
    Draeger DL; Sievert KD; Hakenberg OW
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1215-e1220. PubMed ID: 30201215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer.
    Cerezo O; Oñate-Ocaña LF; Arrieta-Joffe P; González-Lara F; García-Pasquel MJ; Bargalló-Rocha E; Vilar-Compte D
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):684-91. PubMed ID: 22329843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx).
    Cheng HL; Molassiotis A
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):56-62. PubMed ID: 29873180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life and its predictors among patients with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
    Sibhat SG; Fenta TG; Sander B; Gebretekle GB
    Health Qual Life Outcomes; 2019 Nov; 17(1):165. PubMed ID: 31690327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
    Aaronson NK; Ahmedzai S; Bergman B; Bullinger M; Cull A; Duez NJ; Filiberti A; Flechtner H; Fleishman SB; de Haes JC
    J Natl Cancer Inst; 1993 Mar; 85(5):365-76. PubMed ID: 8433390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
    Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
    Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version.
    Montazeri A; Harirchi I; Vahdani M; Khaleghi F; Jarvandi S; Ebrahimi M; Haji-Mahmoodi M
    Qual Life Res; 2000 Mar; 9(2):177-84. PubMed ID: 10983481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring breast cancer-specific health-related quality of life in South Asia: psychometric properties of the Sinhala version of the EORTC QLQ-BR23.
    Jayasekara H; Rajapaksa LC; Brandberg Y
    Qual Life Res; 2008 Aug; 17(6):927-32. PubMed ID: 18500576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a 4-week multimodal rehabilitation program on quality of life, cardiopulmonary function, and fatigue in breast cancer patients.
    Do J; Cho Y; Jeon J
    J Breast Cancer; 2015 Mar; 18(1):87-96. PubMed ID: 25834616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The European Organization for Research and Treatment of Cancer quality of life questionnaire-BR23 Breast Cancer-Specific Quality of Life Questionnaire: psychometric properties in a Moroccan sample of breast cancer patients.
    El Fakir S; Abda N; Bendahhou K; Zidouh A; Bennani M; Errihani H; Benider A; Bekkali R; Nejjari C
    BMC Res Notes; 2014 Jan; 7():53. PubMed ID: 24447401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
    Marks DH; Okhovat JP; Hagigeorges D; Manatis-Lornell AJ; Isakoff SJ; Lacouture ME; Senna MM
    Breast Cancer Res Treat; 2019 Jun; 175(2):267-276. PubMed ID: 30806923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.